Article Text

Download PDFPDF

Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
Free

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Rischin D, Hughes BGM, Basset-Séguin N, et al. High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. J Immunother Cancer 2024;12:e008325. doi: 10.1136/jitc-2023-008325

In this article, the author Axel Hauschild was incorrectly listed as Axel Hausschild.